Back to Search
MARK PALLIS, D.O.
D.O.
Orthopaedic Surgery Physician
NPI: 1538219712IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
ROWAN UNIVERSITY SCHOOL OF OSTEOPATHIC MEDICINE
Class of 1996
Research & Publications (20)
Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds.
PMID 14563480·Biochem Pharmacol·2003
8-other
Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications.
PMID 12804638·Leuk Res·2003
8-other
Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p-glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications.
PMID 12648071·Br J Haematol·2003
8-other
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
PMID 12152989·Leuk Lymphoma·2002
6-review
P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
PMID 10779437·Blood·2000
8-other
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.
PMID 19291085·Br J Haematol·2009
2-rct
Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.
PMID 18509353·Leukemia·2008
8-other
Low dose rapamycin does not modulate p-glycoprotein function in acute myeloid leukaemia.
PMID 17920680·Leuk Res·2008
8-other
Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trials.
PMID 18056183·Clin Cancer Res·2007
8-other
P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors.
PMID 17923246·Exp Hematol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1175 E MOUNTAIN BLVD
WILKES BARRE, PA 18702 - Phone
- (570) 808-1093
Quick Facts
- NPI
- 1538219712
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile